Barbara Chiaramonte
Overview
Explore the profile of Barbara Chiaramonte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bovenzi R, Noce A, Conti M, Di Lauro M, Chiaramonte B, Della Morte D, et al.
Nutrients
. 2024 Jul;
16(13).
PMID: 38999916
Lifestyle factors, such as diet and sleep quality, are receiving increasing interest as accessible therapeutic approaches to migraine. The Mediterranean diet (MD) has shown clear benefits in cardiovascular and metabolic...
2.
Exacoustos C, Ticconi C, Colombi I, Iorio G, Vaquero E, Selntigia A, et al.
Reprod Sci
. 2024 Apr;
31(8):2447-2457.
PMID: 38619796
The current knowledge on adenomyosis as a risk factor for RPL is very scant. Overall 120 women were included in this retrospective observational study. They were divided in three groups...
3.
Tanori M, Pitaro M, Fratini E, Colantoni E, Amoresano A, Celentano S, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839913
Hexedra+ is a nasal spray containing hydroxypropyl methylcellulose, beta-cyclodextrin, and usnic acid. It has been developed with the aim of reducing the risk of transmission of airborne viral infections, with...
4.
Albanese M, Di Girolamo S, Silvani L, Ciaschi E, Chiaramonte B, Conti M, et al.
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768526
Although several cochleo-vestibular symptoms are commonly associated with migraine, only a limited number of studies have been done in this regard. Some reported abnormalities in audiometry, auditory brainstem response and...
5.
Diluvio L, Piccolo A, Marasco F, Vollono L, Lanna C, Chiaramonte B, et al.
Future Sci OA
. 2020 Nov;
6(9):FSO618.
PMID: 33235810
Background: Depression and anxiety are the most common psychiatric comorbidities in chronic spontaneous urticaria (CSU). Omalizumab is a monoclonal antibody approved for CSU treatment. We evaluated the prevalence of anxiety...